CLINICAL_TRIALS
trial_result
· 2019-03-29
Clinical Trial Update: A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors [Phase 1]
Summary
Phase 1 dose-escalation trial of PF-06650808 in advanced solid tumors; terminated with posted results in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Neoplasms, Breast Cancer | Phase 1 | Status: TERMINATED | Results posted: 2019-03-29